Tern Therapeutics develops transformative, one-time genetic treatments for rare diseases.
Tern Therapeutics has raised $15.0M in total funding. The most recent round was Seed. The last funding was announced in August 2024.
Tern Therapeutics's investors include ATW Partners, Steve Oliveira.
Tern Therapeutics is headquartered in Washington, United States.
Tern Therapeutics develops transformative, one-time genetic treatments for rare diseases.
Tern Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tern Therapeutics — Funding & Investors." VCBacked, August 27, 2024, https://www.vcbacked.co/company/tern-therapeutics. Accessed September 14, 2026.
VCBacked. (2024). Tern Therapeutics — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/tern-therapeutics
{{cite web |title=Tern Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tern-therapeutics |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated